pentobarbital has been researched along with Anxiety, Separation in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Anxiety, Separation: Anxiety experienced by an individual upon separation from a person or object of particular significance to the individual.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levine, MF | 1 |
| Hartley, EJ | 1 |
| Macpherson, BA | 1 |
| Burrows, FA | 1 |
| Lerman, J | 1 |
1 trial available for pentobarbital and Anxiety, Separation
| Article | Year |
|---|---|
Oral midazolam premedication for children with congenital cyanotic heart disease undergoing cardiac surgery: a comparative study.
Topics: Administration, Oral; Administration, Rectal; Anxiety, Separation; Atropine; Awareness; Child; Child | 1993 |